Статті для всіх - Praveen ThokalaДокладніше
Доступно в інших місцях: 33
Multicriteria decision analysis to support health technology assessment agencies: benefits, limitations, and the way forward
R Baltussen, K Marsh, P Thokala, V Diaby, H Castro, I Cleemput, M Garau, ...
Value in Health 22 (11), 1283-1288, 2019
Мандати: Netherlands Organisation for Scientific Research
Interventions to improve patient flow in emergency departments: an umbrella review
L De Freitas, S Goodacre, R O’Hara, P Thokala, S Hariharan
Emergency Medicine Journal 35 (10), 626-637, 2018
Мандати: National Institute for Health Research, UK
Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation.
A Pandor, P Thokala, S Goodacre, E Poku, JW Stevens, S Ren, A Cantrell, ...
Health technology assessment 19 (42), 1-102, 2015
Мандати: National Institute for Health Research, UK
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness …
M Westwood, T van Asselt, B Ramaekers, P Whiting, P Thokala, M Joore, ...
Health technology assessment 19 (44), 1-234, 2015
Мандати: National Institute for Health Research, UK
Obesity in older people with and without conditions associated with weight loss: follow-up of 955,000 primary care patients
K Bowman, J Delgado, WE Henley, JA Masoli, K Kos, C Brayne, ...
Journals of Gerontology Series A: Biomedical Sciences and Medical Sciences …, 2017
Мандати: National Institute for Health Research, UK
The return of public health to local government in England: changing the parameters of the public health prioritization debate?
L Marks, DJ Hunter, S Scalabrini, J Gray, S McCafferty, N Payne, ...
Public health 129 (9), 1194-1203, 2015
Мандати: UK Medical Research Council, National Institute for Health Research, UK
Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction
P Thokala, SW Goodacre, PO Collinson, JW Stevens, NL Mills, DE Newby, ...
Heart 98 (20), 1498-1503, 2012
Мандати: US National Institutes of Health, British Heart Foundation
Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care
T Tong, P Thokala, B McMillan, R Ghosh, J Brazier
International journal of geriatric psychiatry 32 (12), 1392-1400, 2017
Мандати: National Institute for Health Research, UK
Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process
BP Reddy, MP Kelly, P Thokala, SJ Walters, A Duenas
Public health 128 (10), 896-903, 2014
Мандати: UK Economic and Social Research Council
Assessing the cost‐effectiveness of Type 1 diabetes interventions: the Sheffield Type 1 Diabetes Policy Model
P Thokala, J Kruger, A Brennan, H Basarir, A Duenas, A Pandor, M Gillett, ...
Diabetic medicine 31 (4), 477-486, 2014
Мандати: National Institute for Health Research, UK
A review of survival analysis methods used in NICE technology appraisals of cancer treatments: consistency, limitations, and areas for improvement
H Bell Gorrod, B Kearns, J Stevens, P Thokala, A Labeit, N Latimer, ...
Medical Decision Making 39 (8), 899-909, 2019
Мандати: National Institute for Health Research, UK, Yorkshire Cancer Research, UK
The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA)—a multicentre parallel-group randomised trial to compare early computerised tomography …
AJ Gray, C Roobottom, JE Smith, S Goodacre, K Oatey, R O’brien, ...
Trials 17, 1-13, 2016
Мандати: National Institute for Health Research, UK
Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
K Marsh, P Thokala, S Youngkong, K Chalkidou
Cost effectiveness and resource allocation 16, 1-9, 2018
Мандати: UK Medical Research Council
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy
F Campbell, P Thokala, LC Uttley, A Sutton, AJ Sutton, A Al-Mohammad, ...
Health technology assessment (Winchester, England) 18 (59), 1, 2014
Мандати: US National Institutes of Health, National Institute for Health Research, UK
Economic, clinical and social impact of simple limbal epithelial transplantation for limbal stem cell deficiency
P Thokala, A Singh, VK Singh, VM Rathi, S Basu, V Singh, S MacNeil, ...
British Journal of Ophthalmology 106 (7), 923-928, 2022
Мандати: Department of Science & Technology, India
HTA’d in the USA: A comparison of ICER in the United States with NICE in England and Wales
P Thokala, JJ Carlson, M Drummond
Journal of Managed Care & Specialty Pharmacy 26 (9), 1162-1170, 2020
Мандати: National Institute for Health Research, UK
Establishing a porcine ex vivo cornea model for studying drug treatments against bacterial keratitis
K Okurowska, S Roy, P Thokala, L Partridge, P Garg, S MacNeil, P Monk, ...
Journal of Visualized Experiments, 2020
Мандати: UK Medical Research Council, UK Research & Innovation
Pertuzumab for the neoadjuvant treatment of early-stage HER2-positive breast cancer: an evidence review group perspective of a NICE single technology appraisal
H Squires, A Pandor, P Thokala, JW Stevens, E Kaltenthaler, M Clowes, ...
Pharmacoeconomics 36 (1), 29-38, 2018
Мандати: National Institute for Health Research, UK
The effectiveness and value of treatments for spinal muscular atrophy: A summary from the institute for clinical and economic review’s New England Comparative Effectiveness …
SD Pearson, P Thokala, M Stevenson, D Rind
Journal of managed care & specialty pharmacy 25 (12), 1300-1306, 2019
Мандати: US National Institutes of Health, Arnold Ventures LLC
Sipuleucel-T for the treatment of metastatic hormone-relapsed prostate cancer: a NICE single technology appraisal; an evidence review group perspective
EL Simpson, S Davis, P Thokala, PR Breeze, P Bryden, R Wong
Pharmacoeconomics 33, 1187-1194, 2015
Мандати: National Institute for Health Research, UK
Дані про публікацію й грошову підтримку визначаються автоматично комп'ютерною програмою